Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For PNXGF
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Bad
0%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q4 Δ in %
Current Ratio -99.81 0.15 80.55
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -80.35 5.14 -26.16
Naive Interpretation member
2 Per Share
Metric Q2 Q4 Δ in %
Book Value -23.19 2.50 3.25
Cash -11.88 10.00 11.34
Capex 0.00 0.00 0.00
Free Cash Flow 226.66 5.30 1.62
Revenue 116.00 18.28 8.46
Naive Interpretation member
3 Profitability
Metric Q2 Q4 Δ in %
Gross Margin 0.00 1.00 1.00
Operating Margin 39.83 0.05 -0.04
ROA -51.68 < 0.005 < 0.005
ROE -35.85 0.05 -0.08
ROIC 93.22 0.05 -0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of PNXGF is permitted for members.
5 Growth
The "Growth Entry" for the Focus of PNXGF is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of PNXGF is permitted for members.